Nachrichten zur Eli Lilly & Co. Aktie

Point Biopharma spikes after Eli Lilly agrees to buy cancer-drug firm for $1.4 bn By Investing.com

Point Biopharma spikes after Eli Lilly agrees to buy cancer-drug firm for $1.4 bn…

Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion

Point Biopharmas shares soared 84% in premarket trading.…

Eli Lilly to acquire Point Biopharma in $1.4B deal

…

Eli Lilly to buy Point Biopharma for $1.4 billion

Eli Lilly and Co has agreed to acquire Point Biopharma Global in an all-cash deal valued at $1.4 billion, the…

Eli Lilly to buy Point Biopharma for $1.4 billion By Reuters

Eli Lilly to buy Point Biopharma for $1.4 billion…

Global Womens Digital Health Market 2023-2030: Bayer, Fitbit, Johnson & Johnson, and Eli Lilly and Novartis Drive Innovation in the Sector

Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Womens Digital Health Market by Type, Distribution Channel, Application…

Nordnet launches new global fund with leverage

Today, Nordnet is launching the mutual fund “Nordnet Index Global 125”. Nordnet’s own fund company Nordnet Fonder is co-manager together…

Eli Lilly eczema therapy rejected in U.S. over manufacturer issues

…

: Eli Lilly gets FDA complete response letter for skin treatment after inspection of third-party facility

APEli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its…

These are the top 4 Club stocks — and the bottom 4 — during the third quarter

Eli Lilly (LLY) was the best-performing Club stock over the past three months, while Foot Locker (FL) was the worst…

Eli Lilly settles whistleblower lawsuit over manufacturing problems By Reuters

Eli Lilly settles whistleblower lawsuit over manufacturing problems…

Eli Lilly benefits as judge overturns $176.5M verdict in Teva patent case

…

US judge overturns Eli Lillys $176.5 million loss in Teva patent case By Reuters

US judge overturns Eli Lillys $176.5 million loss in Teva patent case…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

Eli Lilly (LLY) has been the best-performing Club health care stock by a substantial margin, but we continue to believe…

Eli Lilly wins FDA nod for Jardiance in chronic kidney disease

…

: Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease

Eli Lilly & Co. LLY and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their…

: Eli Lilly set to dominate obesity drug market into the next decade, analysts say

Eli Lilly & Co. LLY is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s,…

Is It Too Late to Buy Eli Lilly Stock?

Shares of the pharmaceutical company have crushed the market so far this year....…

Accused Of Excluding Older Applicants, Eli Lilly Settles Again

Eli Lilly settled another age discrimination lawsuit for an undisclosed amount, just two months after reaching a $2.4 million settlement…

Insiderhandel: Insider verkauft Aktien von Eli Lilly and Company im Wert von 11.645.029$

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-08-24...…

This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring

Some of their winning medicines could soon compete in new markets....…

Top Research Reports for Eli Lilly, UnitedHealth & Walmart

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), UnitedHealth Group Incorporated…

Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?

Chasing indications for NASH has been a pitfall for many pharma companies....…

Eli Lilly succeeds in Phase 3 thyroid cancer trial for Retevmo

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eli Lilly Says LIBRETTO-531 Study Evaluating Retevmo Meets Primary Endpoint

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) announced Tuesday topline results from the LIBRETTO-531 study evaluating Retevmo versus physicians…

5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace

Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo…

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock…

Insiderhandel: Insider verkauft Aktien von Eli Lilly and Company im Wert von 27.306.746$

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-08-15...…

Eli Lilly: Hier passt einfach alles - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Eli Lilly-Aktienanalyse von "Der Aktionär": Martin Weiss, stellvertretender Chefredakteur vom Anlegermagazin "Der Aktionär", nimmt die Aktie von Eli…

This Is What Whales Are Betting On Eli Lilly

3 Reasons to Buy Eli Lilly Stock

Shares of the giant drugmaker arent far off their 52-week high....…

Opening Bell: ExxonMobil, Target, JD.com, Tesla, AMC, Sea Limited, Eli Lilly, Coinbase

Verschärfte Zinssorgen drückten gestern auf die Stimmung der US-Anleger. Für den Dow Jones ging es in Folge dessen um gut…

Opening Bell: US-Anleger vor Fed-Protokoll zurückhaltend; Ölpreis, Exxon Mobil, JD.com, Tesla, Eli Lilly, Coinbase im Fokus

Nach Verlusten am Vortag dürften die US-Börsen zur Wochenmitte stabil starten. Die Anleger warten nicht nur auf die Juni-Daten zur…

Thursday’s Top Analyst Upgrades and Downgrades: Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, Novavax, Nvidia, Qualcomm, Rivian Automotive and More

Thursdays top analyst upgrades and downgrades included Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, International Flavors & Fragrances, LivePerson,…

dpa-AFX ProFeed